Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ride the Tiger with CD -- Ignore unavailable to you. Want to Upgrade?

To: Terry Maloney who wrote (201260)	7/21/2011 11:52:21 AM
From: UPTICK	Read Replies (1) \| Respond to of 313075

M.Fournier, V.P. Tech.and R / D , told me at the AGM that they weren't that far economicallty???? So even if it was 10/15% more expensive than the Bayer receipe, if it is environmentally friendlier it can be a bona fide plus for ORT...as they could licenced the process.

To: Terry Maloney who wrote (201260)	7/21/2011 4:27:38 PM
From: Boolish	2 Recommendations Read Replies (3) \| Respond to of 313075

Well I remain a 'believer' until they prove otherwise.. There is still a lot of paper (and most of it very cheap) floating around out there...plus these spastic markets have really created a trading mentality... There remains unanswered questions of economics like you say. That doesn't really bother me at the moment. Timminco got to 36 bills before it all came crashing down.... Perhaps a poor example but I believe there is ample time to really worry about those details of the trade (liken it too buying the spec of a drill play before the feasibility study)...and hopefully most of us will be averaging our ACB down the entire way up... On todays news I'd look for some target upgrades...perhaps new coverage out of National or others as I've heard...we'll see......